Vyome Holdings, Inc. is a clinical-stage biotechnology and specialty pharmaceutical company focused on developing next-generation therapeutic solutions for immuno-inflammatory diseases, including rare conditions with unmet medical needs. Operating within the healthcare sector under diversified biopharmaceuticals, the company engages in research and development of innovative pharmaceutical products. Vyome Holdings aims to address challenging diseases through advanced therapies, contributing to medical progress in immunology and rare disease treatment.